value will be realized in profit and loss statement in such period. In 1Q2020, the significant change in fair value of derivatives the Company has was from the conversion option embedded in convertible
recognize share of profits from Nava Nakorn Electricity Generating Company Limited (NNEG). Operating highlight in Q4/2017 and 2017 Q4/16 Q3/17 Q4/17 Change +/(-) 2016 2017 Change +/(-) (THB million) QoQ YoY
: () the final offer which will not be changed (subject to the conditions specified in Section 8) ( ) not the final offer and The Tender Offeror may change the Offer Price Pursuant to the Revenue Code of
determined in accordance with the following formula: Sale Shares Price = Permata Book Value (as set out in the last financial statements published prior to the date of confirmation of satisfaction of all
แบบแสดงราการข้อมูลประจำปี Notification of the change of the audit firm Date..... .........................…. Dear Secretary General of the Securities and Exchange Commission of Thailand I would like
exchange Earnings from operation before change in operating assets and liabilities Operating assets (increase) decrease Long-term deposits at financial institutions Securities purchased under reverse
securities (Gain) Loss from assets distribution (Gain) Loss from foreign currencies exchange Earnings from operation before change in operating assets and liabilities Operating assets (increase) decrease Long
off (Gain) Loss from regulation of securities (Gain) Loss from assets distribution (Gain) Loss from foreign currencies exchange Earnings from operation before change in operating assets and liabilities
Q3/16 Q2/17 Q3/17 Change +/(-) 9M/16 9M/17 Change +/(-) (Unit: THB million) QoQ YoY 9M Operating revenue 5,176 5,459 4,243 (22%) (18%) 16,214 15,067 (7%) Gross profit 1,046 1,256 1,199 (5%) 15% 3,485
www.interpharma.co.th IP_OCS/011/2020 8th June 2020 Subject: Notify the Resolutions of the Board of Directors Meeting, Change of Objectives of Funds Usage, Acquisition of Assets, The Issuance of Debentures and Fix the